Financial statements Ima Pharma

Balance sheet of Ima Pharma

Company age:
Age:
16 y. 8 m. 24 d.
Share capital:
Share capital:
800 000 PLN

Balance sheet data of IMA PHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 971 371,84 1 524 746,42 1 927 345,91 2 085 607,78 2 410 730,29 2 319 745,63
A. Fixed assets 3 902,50 65 084,33 111 334,55 123 979,35 141 833,76 129 484,78
B. Current assets 967 469,34 1 459 662,09 1 816 011,36 1 961 628,43 2 268 896,53 2 190 260,85
C. Share capital contributions (basic funds) - 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) - 0,00 0,00 0,00 0,00 0,00
Total liabilities 971 371,84 1 524 746,42 1 927 345,91 2 085 607,78 2 410 730,29 2 319 745,63
A. Equity 273 141,46 241 472,25 284 463,69 371 937,78 545 329,41 331 339,21
B. Liabilities and provisions for liabilities 698 230,38 1 283 274,17 1 642 882,22 1 713 670,00 1 865 400,88 1 988 406,42
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 673 493,45 1 257 929,18 1 594 753,72 1 664 389,32 1 734 541,11 1 876 286,34
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.